Civilization Ventures backs scientific founders developing cutting‑edge health‑tech and biology solutions, with a focus on genomics, diagnostics, synthetic biology, and gene‑cell therapies. The firm provides “mentor capital,” fostering founder growth rather than replacing them, and leverages a global network of life‑science experts to source and support transformative innovations.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
65.1%United Kingdom
6.3%Canada
3.2%Australia
1.6%Brazil
1.6%Other
9.6%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series A
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
CV Fund I
Vintage 2017 • $1.0
CV Fund II
Vintage 2020 • $35.0
Civilization Ventures III LP
Vintage 2025 • $13.5
Civilization Ventures Anchor LP
Vintage 2025 • $1.3
Civilization Ventures Apollo LP
Vintage 2025 • $6.9
Civilization Ventures Rebirth LP
Vintage 2024 • $9.0
Civilization 415 Investments Ample LP
Vintage 2023 • $7.3
Civilization Ventures B21 LP
Vintage 2023 • $8.1
Civilization Ventures Digital Health LP
Vintage 2023 • $0.8
Civilization Ventures DNA LP
Vintage 2023 • $0.0
Civilization Ventures FFHI LP
Vintage 2023 • $0.8
Civilization Ventures Galata LP
Vintage 2023 • $7.5
CV Opportunity Fund
Vintage 2023